KFSHRC's New US Patent Promises Innovative Approach To Breast Cancer Treatment

King Faisal Specialist Hospital & Research Centre (KFSHRC) has achieved a milestone in stem cell research by obtaining a US patent. This breakthrough method, developed by researchers Abdelilah Aboussekhra, Huda H. Al-Khalaf, and Hazem Ghebeh, could revolutionise breast cancer treatment and regenerative medicine. The technique involves converting regular breast cells into multipotent stem cells through specialised culture methods.

These newly developed stem cells have demonstrated the ability to regenerate mammary tissue in animal models. This discovery opens up new avenues for breast tissue reconstruction and advanced cancer therapies. The foundational research was published in the Molecular and Cellular Biology journal, highlighting its scientific significance.

This innovation provides a promising foundation for personalised breast cancer treatment. It offers enhanced reconstruction options for patients during the post-surgery period. Beyond regenerative medicine, this technique underscores KFSHRC's commitment to developing life-saving therapies that meet the needs of cancer patients globally.

KFSHRC is renowned for its leadership in advanced therapies, including localised CAR T-cell treatment for cancer. The hospital continues to set new standards in personalised care and transformative medical research, aiming to improve therapeutic outcomes worldwide.

KFSHRC has been ranked first in the Middle East and Africa and 20th globally among the world's top 250 Academic Medical Centres for two consecutive years. It has also been recognised as the most valuable healthcare brand in Saudi Arabia and the Middle East according to the 2024 Brand Finance rankings.

In addition, KFSHRC was listed among the world's best 250 hospitals and included in Newsweek magazine's World's Best Smart Hospitals list for 2025. These accolades reflect its dedication to excellence in healthcare and innovation.

This pioneering work at KFSHRC not only advances regenerative medicine but also sets a benchmark for future research efforts aimed at improving patient care worldwide.

With inputs from SPA